← All stocks

Hims & Hers Health, Inc.

HIMS Mostly scheduled
CIK 0001773751 #1079 in the set updated 17 Sep 2026
Bought (12 mo)
$1.17M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$41.50M
$19.07M on a plan · $22.33M straight out of an exercise
Sold at will
$97.93K
1 of 61 sales
Net
−$40.33M
+$1.08M against sales at will

By person

16 insiders · 62 transactions
65.0×

Mr. Dudum holds 65.0 times base salary in stock. $32.20M of shares against $494.79K in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Dudum last reported holding, valued at $28.33, the price Class A Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Okupe Oluyemi
Chief Financial Officer
$16.20M (21) scheduled
−$16.20M
264,117
0.114%
$7.48M
+20.2%
Dudum Andrew
Chief Executive Officer
$14.32M (10) scheduled
−$14.32M
1,136,583
0.490%
$32.20M
−69.1%
Chi Michael
Chief Operating Officer
$4.23M (7) scheduled
−$4.23M
470,687
0.203%
$13.33M
+112.5%
Boughton Soleil
Chief Legal Officer
$2.03M (11) scheduled
−$2.03M
310,506
0.134%
$8.80M
+73.2%
Carroll Patrick Harrison
Chief Medical Officer
$1.70M (3) scheduled
−$1.70M
197,847
0.085%
$5.61M
−7.3%
Becklund Irene
PAO
$1.24M (5) scheduled
−$1.24M
13,985
0.006%
$396.20K
−7.6%
WELLS DAVID B
Director
$1.17M (1)
+$1.17M
229,808
0.099%
$6.51M
+17.2%
Elshenawy Mohamed
CTO
$946.26K (1) scheduled
−$946.26K
193,510
0.084%
$5.48M
Autor Deborah M.
Chief Policy Officer
$726.08K (2) scheduled
−$726.08K
48,961
0.021%
$1.39M
Perez Garcia Andrea G
Director
$97.93K (1)
−$97.93K
83,822
0.036%
$2.37M
+15.2%
Baird Melissa
Chief Operating Officer
805,083
0.347%
$22.81M
+27.6%
Cosgrove Delos M.
Director
67,995
0.029%
$1.93M
+25.0%
Pendarvis Christiane
Director
55,430
0.024%
$1.57M
+131.8%
Manuel Anja
Director
38,671
0.017%
$1.10M
Payne Christopher D
Director
34,863
0.015%
$987.67K
Schultz Kare
Director
26,020
0.011%
$737.15K
Insider
Date
Role
Action
Shares
Price
Amount
WELLS DAVID B
26 May 2026
Director
Buy
48,400
$24.24
$1.17M

What was left out

Form 4 filings counted 127
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 31
Sales straight out of an exercise 29
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 17,838,060
History held since 22 Jan 2021